Tirzepatide — lab test, August 2026
This lab doesn't publish a public lookup, so we can't confirm the certificate against the lab's own record. The document was reviewed before publication, but it rests on our review alone.
What portal verification means →Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 50 mg · Lab measured 61.6 mg
123% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 15.4 mg using the measured mass, against 12.5 mg on the label — 23% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | Z2HF-22YK |
|---|---|
| Portal lookup | Lab has no portalThis laboratory publishes no public lookup, so the report cannot be confirmed independently. |
| PDF vs portal | Accumark Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide, performed by Accumark Labs on August 2, 2026. Reported purity: 99.97%. Net content: 61.6 mg against 50 mg labeled (123% of label). Tested content exceeds the labeled amount by 23%. Batch POL-T50-7. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion